Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, JVN

OrthoVentions Invests in Gemini(OV) to Revolutionize Musculoskeletal Imaging through its Digital Twin Platform


ATLANTA, Oct. 31, 2023 /PRNewswire/ -- OrthoVentions LLC today announced its investment in GeminiOV, an early-stage company created in partnership with the Hospital for Special Surgery (HSS). GeminiOV is developing novel MRI-imaging and volumetric analysis solutions to provide non-invasive and interactive 3D views inside of joints ? creating a digital twin.

GeminiOV developing novel interactive 3D images of joints ? creating an orthopedic digital twin.   

"GeminiOV has the potential to reshape how we leverage musculoskeletal MRI images to assist in evaluating joint health, optimize surgical planning, and enhance patient engagement," said Dr Andy Pearle, Co-Founder of GeminiOV, and Chief of Sports Medicine at HSS. "Our technology uses proprietary AI-based algorithms to deliver a real-time volumetric assessment of joint health and provide surgeons a critical 3D view of the joint. This fundamentally improves the efficiency and precision of the legacy MRI-imaging investments."

Under the terms of the investment, the company will be funded to complete product development and an initial commercial launch targeting the rapidly growing musculoskeletal imaging and surgical planning market. The initial application will focus on creating a digital twin of the knee recognizing that each year over 1.8 million knee procedures are performed in the US alone. The company will also dedicate resources to expand its product pipeline to deliver digital twin solutions for the shoulder, hip, foot and ankle.

Jagi Gill, Founder and Managing Director of OrthoVentions, said, "We are excited to partner with Dr Pearle and the rest of the team to bring this compelling technology to market. This investment serves as a blueprint for OrthoVentions where we partner with surgeon-inventors to identify, develop, and launch innovation utilizing a blend of best-in-class service partners across product development, marketing and regulatory affairs.

About OrthoVentions:
OrthoVentions LLC is a dedicated healthcare fund collaborating with the Hospital for Special Surgery to identify and develop novel technologies developed by their premiere musculoskeletal surgeons. The principals at OrthoVentions bring a strong track record as founders and operators of medical technologies companies with a rich experience in developing and commercializing compelling healthcare solutions. (www.orthoventions.com)

About GeminiOV:

GeminiOV is a cloud-based technology platform that unlocks the full potential of MRI through advanced AI guidance and enhanced visualization algorithms. It is pioneering a new era of patient-friendly orthopedic innovation that will bring new levels of precision to how healthcare professionals assess, predict, and manage joint health. (www.geminiov.com)

Contact:
Rom Papadopoulos
Chief Financial Officer
OrthoVentions LLC
[email protected]

SOURCE OrthoVentions LLC


These press releases may also interest you

at 06:15
The "Marine Battery Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2019-2029" report has been added to ResearchAndMarkets.com's offering. The Global Marine Battery Market was valued at USD 3.08 billion in 2023 and is...

at 06:15
Imagine Learning, the largest provider of digital curriculum solutions in the United States, and eDynamic Learning, the leader in K?12 college and career readiness solutions, today announced Imagine Learning as the primary third-party reseller of...

at 06:05
United Therapeutics Corporation , a public benefit corporation, announced today that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company's operations during a fireside chat session at...

at 06:05
Ouster, Inc. ("Ouster" or the "Company"), a leading provider of high-performance lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries, announced today that it will report its financial results for the fourth...

at 06:05
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation (NEC; TSE: 6701), a leader in IT, network and AI technologies and BostonGene Corporation...

at 06:05
Quest Technology Management is proud to announce a groundbreaking managed service partnership with Samsung, bringing an innovative digital signage solution exclusively to Telarus technology advisors. This collaboration marks a significant milestone...



News published on and distributed by: